<table id="ID135" width="99%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3 Average Pharmacokinetic Parameters of Ceftriaxone in Pediatric Patients with Meningitis</caption>
<col span="1" width="57%"></col>
<col span="1" width="21%"></col>
<col span="1" width="21%"></col>
<tbody>
<tr>
<td>
<br/>
</td>
<td>
<content stylecode="bold">50 </content>
<content stylecode="bold">mg</content>
<content stylecode="bold">/</content>
<content stylecode="bold">kg </content>
<content stylecode="bold">IV</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td>
<content stylecode="bold">75 </content>
<content stylecode="bold">mg</content>
<content stylecode="bold">/</content>
<content stylecode="bold">kg </content>
<content stylecode="bold">IV</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td>Maximum Plasma Concentrations (mcg/mL)<br/>
</td>
<td>216<br/>
</td>
<td>275<br/>
</td>
</tr>
<tr>
<td>Elimination Half-life (hr)<br/>
</td>
<td>4.6<br/>
</td>
<td>4.3<br/>
</td>
</tr>
<tr>
<td>Plasma Clearance (mL/hr/kg)<br/>
</td>
<td>49<br/>
</td>
<td>60<br/>
</td>
</tr>
<tr>
<td>Volume of Distribution (mL/kg)<br/>
</td>
<td>338<br/>
</td>
<td>373<br/>
</td>
</tr>
<tr>
<td>CSF Concentration – inflamed meninges (mcg/mL)<br/>
</td>
<td>5.6<br/>
</td>
<td>6.4<br/>
</td>
</tr>
<tr>
<td>   Range (mcg/mL)<br/>
</td>
<td>1.3 to 18.5<br/>
</td>
<td>1.3 to 44<br/>
</td>
</tr>
<tr>
<td>   Time after dose (hr)<br/>
</td>
<td>3.7 (± 1.6)<br/>
</td>
<td>3.3 (± 1.4)<br/>
</td>
</tr>
</tbody>
</table>